Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05530915 · ClinicalTrials.gov registry record · NA
Guayusa: The Effect of an Herbal Extract on Alertness and Mental Fatigue
A NA study, sponsored by PepsiCo Global R&D.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT05530915 is a NA study that has completed, run by PepsiCo Global R&D. The registered enrollment target is 60 participants.
The verdict
NCT05530915, a NA study, has completed, sponsored by PepsiCo Global R&D.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
The primary objective of this randomized, double-blind, placebo-controlled, cross-over study is to assess the acute effects of a novel ingredient, guayusa on alertness and mental fatigue compared to a placebo. This trial will utilize the COMPASS cognitive task and cognitive demand battery (CDB) and mood, motivation, and energy measures with assessments taking place at baseline, 60- and 120-minutes post treatment on three separate testing days separated by \~7 days.
Interventions
- OTHER Gel capsule
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2022-07-27 |
| Est. Completion | 2022-11-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05530915
The ClinicalTrials.gov registry entry for NCT05530915 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is PepsiCo Global R&D, which has 47 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Gel capsule is the first listed.
NCT05530915 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05530915 about?
NCT05530915 is a clinical study titled "Guayusa: The Effect of an Herbal Extract on Alertness and Mental Fatigue". The primary objective of this randomized, double-blind, placebo-controlled, cross-over study is to assess the acute effects of a novel ingredient, guayusa on alertness and mental fatigue compared to a placebo. This trial will utilize the COMPASS cognitive task and cognitive demand battery (CDB) and ...
What is the current status of trial NCT05530915?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2022-07-27. Estimated completion is 2022-11-07.
What interventions are being tested in trial NCT05530915?
The interventions under investigation include: Gel capsule (OTHER).
Who is sponsoring clinical trial NCT05530915?
This trial is sponsored by PepsiCo Global R&D, which has 47 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.